Funds and ETFs Astellas Pharma Inc.

Equities

4503

JP3942400007

Pharmaceuticals

Market Closed - Japan Exchange 07:00:00 26/04/2024 BST 5-day change 1st Jan Change
1,506 JPY +3.51% Intraday chart for Astellas Pharma Inc. +1.72% -10.68%

ETFs positioned on Astellas Pharma Inc.

Name Weight AuM 1st Jan change Investor Rating
11.47% 15 M€ +7.34%
2.09% 251 M€ +13.17%
2.01% 57 M€ +19.27%
1.99% 11 M€ +10.37% -
1.65% 174 M€ -.--% -
1.65% 51 M€ -.--% -
1.61% 15 M€ +14.10%
1.31% 31,732 M€ +14.31% -
1.30% 1,198 M€ +13.48% -
1.22% 81 M€ +14.05%
1.20% 4 M€ +13.95%
1.19% 67,864 M€ +14.28%
1.18% 16,729 M€ +13.38% -
1.12% 73 M€ +11.61%
0.94% 60 M€ +14.42%
0.89% 10,207 M€ +14.32%
0.89% 5,115 M€ +13.58%
0.89% 14 M€ +15.63%
0.75% 18 M€ +16.15% -
0.67% 26 M€ +20.62%
0.65% 66,066 M€ +14.68% -
0.65% 144,586 M€ +14.49%
0.65% 20,721 M€ +13.52% -
0.42% 717 M€ +6.20%
0.35% 4 M€ -.--% -
0.35% 1,120 M€ +0.40%
0.30% 469 M€ -2.05% -
0.30% 3,859 M€ +18.82% -
0.15% 10 M€ -3.35% -
Astellas Pharma Inc. specializes in the research, development, manufacturing and marketing of pharmaceutical products. Products are especially for immune diseases, infectious diseases, skin diseases, cancer and urologic disorders. Net sales are distributed geographically as follows: Japan (28.8%), Americas (34.5%) and others (36.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
1,506 JPY
Average target price
2,025 JPY
Spread / Average Target
+34.46%
Consensus
  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. Funds and ETFs Astellas Pharma Inc.